Cannabis. Member of the Cannabaceae family of flowering plants (along with hops) Cannabis sativa (v. sativa, indica, afghanica, ruderalis)

Similar documents
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

Marijuana and cannabinoids

The Scientific Side of Medical Marijuana

Research on Cannabis and PD: Is there any evidence?

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

(THC) Delta9-tetrahydrocannabinol:

History Of Medical Cannabis

Investigational Pharmacy Cannabidiol treatment in Epilepsy

Marijuana and Adolescents: Truth and Consequences. Disclosure Statement OBJECTIVES. Secondary Objectives. State of Marijuana in US

CANNABIS FOR THE RHEUMATOLOGIST

Trichomes: Crystalline structures that coat parts of the cannabis plant that hold the majority of the cannabinoid content.

At a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate

Responsibility through testing THE HANDBOOK. Understanding Your Laboratory

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

PAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)

marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD

Cannabidiol as a potential treatment for anxiety disorders. Esther Blessing, MD PhD

Pennsylvania House of Representatives. Joint Health and Judiciary Committee Hearing. Medical Cannabis - Health Care Forum

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Cannabis in the Community

Medical Marijuana in Canada, 2014: Panacea or Blowing Smoke. Dr. Paul Daeninck Mr. Brent Zettl

MEDICAL MARIJUANA: WHAT S THE EVIDENCE?

Action Potentials and Synaptic Transmission. BIO 219 Napa Valley College Dr. Adam Ross

MARIJUANA & THE EFFECTS ON THE BRAIN

Introduction to Medical Cannabis

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

Legislation restricted all narcotics, including cannabis, as poisons required prescriptions antispasmodic

WHO Expert Committee on Drug Dependence Pre-Review: Extracts and tinctures of cannabis. Expert Peer Review 2

CANNABINOIDS and HALLUCINOGENS

420 ADVISORY MANAGEMENT

WHAT SHOULD WE KNOW ABOUT MARIJUANA

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

A look at Marijuana in 2014

Federal Law: Marijuana

Medical Marijuana Martin P. Eason MD, JD Associate Chief of Staff for Education Mountain Home VA Medical Center. Disclosure.

Recreational drugs 10/11/2014. Drugs of abuse: Recreational drugs. Tobacco. Absorption of Nicotine (pharmacokinetics)

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

Cell body, axon, dendrite, synapse

Cannabis: Therapeutic properties of the plant

PHYTOCANNABINOIDS AND THEIR MEDICINAL APPLICATIONS

ALCOHOL Other name(s): ethyl alcohol, ethanol, grain alcohol, hootch, liquor, booze, firewater, EtOH Class: alcohols are molecules with a hydroxyl

Special Topic: Drugs and the Mind

Medical Cannabis. Christine Yoshioka, NP

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

Biology 3201 Nervous System #6: Effects of Drugs at Synapses

Ultimate Guide: Everything You Need To Know Before Buying CBD Hemp Oil

HEALTH WELLNESS COMMUNITY

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD

Cell communication. Gated ion channels. Allow specific ions to pass only when gates are open

Cell communication. Gated ion channels. Voltage-Gated Na + Channel. Allow specific ions to pass only when gates are open

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD

Medicinal Cannabis Dosage Forms in California

James Donaldson CEO and Executive Director

Medical Cannabis use in the Older Patient

Cannabis in the treatment of Autism:

Medical Cannabis use in the Older Patient. Amanjot Sidhu, MD, FRCPC Division of Geriatric Medicine McMaster University

Nervous System, Neuroanatomy, Neurotransmitters

Psychotropic Drugs Critical Thinking - KEY

CANNABIS AND CANADA S CHILDREN AND YOUTH CPS Podcast

MEDICAL CANNABIS IN MINNESOTA

The Nervous System Mark Stanford, Ph.D.

Puget Sound Educational Service District

MEDICAL CANNABIS IN MINNESOTA

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

Cannabis & Hemp therapeutic solutions

WHO Expert Committee on Drug Dependence Pre-Review: Cannabis plant and resin. Expert Peer Review 2

THE COMPLETE CBD GUIDE

Cannabinoids (CB): Outline. CB: Epidemiology. CB: Categorization. CB: Pharmacodynamics. Part #1: Cannabinoid (CB) Primer.

Cannabis 101 Safe, Versatile & Effective

Marijuana for Medical Use Patient Information

MD GUIDE TO USING MEDICAL CANNABIS

EMERGING ISSUES IN SMOKING CESSATION

Visit: NEHA s Online Cannabis Resources

Medical Cannabis MATT WEBSTER DO, MS

CANAM INTERVENTIONS. Addiction

I would like to begin by acknowledging that we are on the ancestral grounds of the Beothuk people

Medical Marijuana: The Move to Schedule II

CANNABINOIDS: NOVEL MOLECULES WITH SIGNIFICANT CLINICAL UTILITY

Slide 1 Is Marijuana Medicine?

PRODUCT MONOGRAPH. LGP CLASSIC oil range medicinal cannabis

WHAT TO REMEMBER ABOUT CANNABIS HISTORY

Weeding Through the Science of Cannabis. Ryan Vandrey, PhD

Marijuana. Module 4 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER

The Nervous System. Chapter 4. Neuron 3/9/ Components of the Nervous System

Learning Objectives 1/8/2019. Therapeutic Potential of the Marijuana-Derived Cannabinoids THC and CBD. Disclosures. Outline. Take home messages

CBD HOPE AND/OR HYPE?

A Primer About Cannabidiol And The Benefits of CBD

Medical Cannabis: A Patient Primer

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Medical Marijuana Myths and Realities

The Return of Medicinal Cannabis

Biological Psychology 2012 Spring 2005 Patterson

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Outline. Part I: Nick Jikomes The cannabis plant Cannabinoids & psychoactivity. Part II: John Hatch Marijuana and human health

Medical Cannabis Then and Now. Jeffrey Skell, PhD

Transcription:

Member of the Cannabaceae family of flowering plants (along with hops) sativa (v. sativa, indica, afghanica, ruderalis)

Only females flowers contain high concentrations of psychoactive oils (cannabinoids) oils are in the sticky trichomes that develop to catch male pollen (overbred) hashish (hash) = pure trichomes same effects, but a more potent preparation

Unique spectrum of effects: low doses similar to low doses of ethanol a depressant with some stimulant properties at higher doses, mildly psychedelic little to no risk of overdose dream-like / euphoric state anxiolytic (sometimes anxiogenic - set and setting ) analgesia altered / enhanced sensory perception altered attention / impaired STM increased appetite dilated corneal blood vessels / dry mouth / reduced temperature

the trichomes contain aromatic oils known as terpenes Phytocannabinoids (~80+) - A few of the big players: tetrahydrocannabinol (THC) major constituent of high-grade recreational marijuana amount varies with form of cannabis (2-30%) stimulant / mildly hallucinogenic / psychotomimetic? euphoria analgesic reduce nausea / vomiting stimulate appetite reduce muscle spasms neurogenesis?

cannabinol (CBN) oxidized THC - major constituent of low-grade / degraded cannabis depressant / stony analgesic sleep inducing anti-spasmodic

cannabidiol (CBD) isomer of THC mild sedative effects / antipsychotic analgesic anti-bacterial reduces blood sugar reduced nausea / vomiting anti-seizure anti-inflammatory anti-tumor anti-psychotic anti-muscle spasm anxiolytic modulates immune system neuroprotective - high CBD / low THC varieties being developed for medicinal use

same plant, selectively bred for: industry ( hemp ) - low THC, high fiber conten recreation ( marijuana ) - high THC sativa vs indica paranoid - sativa tired - indica ( in-da-couch ) medicine ( cannabis ) - high CBD

Pharmacokinetics - smoking 1 g (1000 mg) of cannabis @ 10% potency > 100 mg THCa tetrahydrocannabinolic acid 1 cigarette (.5 g joint ) @ contains ~50 mg THCa non-psychoactive THCa must be heated to remove CO2 ( decarboxylated ) > psychoactive THC ~2/3 of THC destroyed and/or goes up in smoke (inhale ~17 mg) only about 20-40% of the inhaled THC (~5-10 mg) is absorbed through the lungs into the bloodstream only ~10-20% efficiency, but very rapid smoking is not generally associated with long-term lung problems blunts = cannabis rolled in a cigar wrapper (tobacco) phytocannabinoid oils are potent antioxidants vaporization allows inhalation of oils without smoke particulates

as with tobacco / nicotine, smoking or vaporizing allows quick and easy dosageadjustments plasma THC levels of ~5-100 ng/ml produce desired psychoactive effects peak plasma levels in about 10 minutes, effects felt for a couple of hours THC eventually metabolized into 11-hydroxydelta-9-thc (more potent than THC) then thccarboxy (non-active) by CyP450 enzymes

Pharmacokinetics - eating Oral ingestion of.5 g cannabis w/ 50 mg THCa normally orally inactive - must be heated first to decarboxylate 1st-pass metabolism (CyP450 enzymes) gets 80-90% 1st metabolite (11-hydroxy-delta-9-THC) is very psychoactive and its effects may last several hours only 5-10 mg of THC is absorbed into the bloodstream only ~10-20% efficiency (same as smoking), but very slow onset delayed peak plasma levels in a couple of hours, effects felt for longer than smoking slow metabolism allows for more 11-hydroxy-delta-9- THC activity > more psychedelic effects

Pharmacokinetics half-life of about 30 hrs+ THC is a fatty acid that binds with fatty material in body (like the brain) metabolites even longer - detectable in urine of heavy users for up to a month reverse tolerance in chronic users, THC is stored up and slowly released from fatty tissues ingesting even small amounts may temporarily augment the stored THC to bring plasma levels to the psychoactive zone (~5 ng/ml of blood)

Pharmacodynamics THC binds with cannabinoid (CB) receptors in CNS & PNS large numbers of CB receptors (probably more than any other type) CB1, CB2, (GPR55 +?) endogenous cannabinoids - agonists anandamide 2-arachidonoylglycerol (2-AG)

Pharmacodynamics CB1 (mostly CNS): cortex (especially frontal lobe) - mild hallucinogenic properties hippocampus - memory encoding impairments basal ganglia, cerebellum - impaired movement/ coordination spinal cord - analgesic properties very few in brainstem - respiration / vital functions unaffected

Pharmacodynamics CB2 (almost exclusively peripheral) - immune / anti-inflammatory (analgesic) expressed on immune system T-cells and peripheral nerve terminals THC will bind with both CB1 and CB2 receptors (CNS and PNS) CBD mainly binds to CB2 (PNS)

Pharmacodynamics CB receptors are G-protein receptors generally on axon terminals ( presynaptic ) Post-synaptic neurons release membrane-bound endocannabinoids in response to ligand-receptor binding Retrograde messenger released from postsynaptic dendrites and binds to presynaptic CB1 receptors increases potassium (K+) efflux blunts depolarization inhibits calcium influx blunts exocytosis So. NT activity leads to inhibition of NT release from presynaptic terminals ( putting on the brakes ) presynaptic inhibition

Pharmacodynamics Anandamide and 2-AG modulate levels of overall neuronal activity, depending on location in brain: inhibiting GABAergic transmission net result of increased excitation due to a lack of inhibition in postsynaptic neurons inhibiting glutamatergic transmission net result of decreased excitation due to a lack of excitation in postsynaptic neurons high levels of CB receptor activity (e.g., after ingestion of THC) activate the endogenous opioid system, inducing release of DA into nucleus accumbens, etc

Too much disruption of STM (encoding and retrieval) usually only while under the effects reversed by cannabinoid antagonists Tolerance: cannabinoid receptor downregulation rapidly returns to normal after THC withdrawal Withdrawal / discontinuation effects are mostly psychological...but some some people experience mild physical discomfort for a few days

Too much Heavy use (3-5+ joints / day): cognition slowed, associated with dosedependent lowering of IQ not permanent - IQ returns to normal after drug is completely gone (up to a month for heavy users) associated with use of other illicit drugs amotivational syndrome : depression, selfmedicating?